Selim Mısırlıoğlu

New York City Health and Hospitals Corporation

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “CCNE1 amplification among metastatic sites in patients with gynecologic high-grade serous carcinoma”.

CCNE1 amplification among metastatic sites in patients with gynecologic high-grade serous carcinoma

Gynecologic Oncology Reports(2021)10.1016/j.gore.2021.100850

N/A

0.292DataRank · unranked

6 citations

Fanny Dao, Michael Licciardi, Selim Mısırlıoğlu, Narciso Olvera, Sitharam Ramaswami +2 more

Drug-induced adaptation along a resistance continuum in cancer cells

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.06.21.496830

N/A

0DataRank · unranked

23 citations

Maayan Baron, Maayan Pour, Benjamin R. King, Anjali Rao, Selim Mısırlıoğlu +10 more

Cellular adaptation to cancer therapy along a resistance continuum

Nature(2024)10.1038/s41586-024-07690-9

N/A

0DataRank · unranked

160 citations

Maayan Baron, Benjamin R. King, Jozef P. Bossowski, Alicia Bjornberg, Maayan Pour +16 more

SPL-108 mitigates metastasis and chemoresistance in tubo-ovarian carcinoma

Translational Oncology(2024)10.1016/j.tranon.2024.102168

N/A

0DataRank · unranked

1 citations

Elke Van Oudenhove, Luiza Pereira, Selim Mısırlıoğlu, Douglas A. Levine, Kari Hacker +1 more

SPL-108 mitigates metastasis and chemoresistance in tubo-ovarian carcinoma

UNC Libraries(2024)10.17615/vs82-f903

N/A

0DataRank · unranked

0 citations

Elke Van Oudenhove, Douglas A. Levine, Olivia D. Lara, Kari Hacker, Selim Mısırlıoğlu +1 more